Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 42Leukemia, Lymphocytic, Chronic, B-Cell 41Lymphoma 30Myelodysplastic Syndromes 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 19Lymphoma, Non-Hodgkin 18Hodgkin Disease 18Leukemia, Myeloid, Acute 17Multiple Myeloma 16Myeloproliferative Disorders 14Lymphoma, Mantle-Cell 10Lymphoma, Follicular 10Neoplasms, Plasma Cell 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, B-Cell, Marginal Zone 9Leukemia, Myeloid, Chronic-Phase 9Congenital Abnormalities 9Lymphoma, T-Cell, Peripheral 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Hematologic Neoplasms 8Burkitt Lymphoma 8Anemia, Aplastic 8Waldenstrom Macroglobulinemia 7Recurrence 7Myelodysplastic-Myeloproliferative Diseases 7Lymphoma, Large-Cell, Immunoblastic 7Primary Myelofibrosis 6Leukemia, Myelomonocytic, Chronic 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Leukemia, Myeloid, Accelerated Phase 6

Interventions

fludarabine 6fludarabine phosphate 5Rituximab 5Cyclophosphamide 5Busulfan 4blinatumomab 3Lenalidomide 3thymoglobulin 2Whole-Body Irradiation 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Methotrexate 2Melphalan 2Bone Marrow Transplantation 2Biopsy 2Bendamustine Hydrochloride 2Behavior Therapy 2Alemtuzumab 2venetoclax 1sargramostim 1romiplostim 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1lirilumab 1ibrutinib 1duvelisib 1copanlisib 1Vincristine 1Thiotepa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Lymphoid × Alemtuzumab × Clear all
NCT00935792 2017-09-26

Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Mayo Clinic

Phase 1/2 Completed
28 enrolled 13 charts
Other hematologic neoplasm

Leukemia, Lymphoid, Hematologic Neoplasms

NCT00683046 2016-11-22

T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies

University of Chicago

Phase 2 Completed
204 enrolled 7 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Leukemia, Lymphoid, Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡